Table 3.
Proportions of selected aetiologic diagnoses according to purpose of travel and region of exposure, GeoSentinel Surveillance Network, 2000–12
| Reason for travel (col %)
|
Region of exposurea (col %)
|
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Business n = 1394 | MVRA n = 2379 | Student n = 593 | Tourist n = 3656 | VFR n = 1580 | Latin Americab n = 3547 | Asia n = 1795 | Sub-Saharan Africa n = 2199 | Middle East/North Africa n = 368 | Otherc n = 742 | |
| Acute diarrhoea due to Giardia spp., n = 359 | 68 (4.9) | 87 (3.7) | 22 (3.7) | 126 (3.4) | 55 (3.5) | 108 (3.0) | 87 (4.8) | 93 (4.2) | 26 (7.1) | 12 (1.6) |
| Post-infectious irritable bowel syndrome, n = 591 | 87 (6.2) | 233 (9.8) | 33 (5.6) | 217 (5.9) | 18 (1.1) | 237 (6.7) | 97 (5.4) | 62 (2.8) | 22 (6.0) | 56 (7.5) |
| Strongyloidiasis (simple intestinal), n = 206 | 11 (0.8) | 58 (2.4) | 11 (1.9) | 42 (1.1) | 84 (5.3) | 86 (2.4) | 30 (1.7) | 60 (2.7) | 3 (0.8) | 5 (0.7) |
| Schistosomiasis (S. mansoni), n = 92 | 7 (0.5) | 46 (1.9) | 7 (1.2) | 14 (0.4) | 18 (1.1) | 5 (0.1) | 1 (<0.1) | 59 (2.7) | 16 (4.3) | 2 (0.3) |
| Malaria (P. falciparum), n = 328 | 28 (2.0) | 44 (1.8) | 14 (2.4) | 34 (0.9) | 208 (13.2) | 26 (0.7) | 7 (0.4) | 281 (12.8) | 5 (1.4) | 1 (0.1) |
| Dengue fever, n = 209 | 23 (1.6) | 53 (2.2) | 11 (1.9) | 72 (2.0) | 50 (3.2) | 123 (3.5) | 49 (2.7) | 23 (1.0) | 1 (0.3) | 7 (0.9) |
| Enteric fever, n = 106 | 9 (0.6) | 21 (0.9) | 2 (0.3) | 32 (0.9) | 42 (2.7) | 30 (0.8) | 53 (3.0) | 17 (0.8) | 0 (0.0) | 2 (0.3) |
| Rickettsiosis, n = 82 | 6 (0.4) | 14 (0.6) | 2 (0.3) | 57 (1.6) | 3 (0.2) | 4 (0.1) | 5 (0.3) | 68 (3.1) | 2 (0.5) | 2 (0.3) |
| Cutaneous leishmaniais, n = 98 | 9 (0.6) | 22 (0.9) | 13 (2.2) | 44 (1.2) | 10 (0.6) | 67 (1.9) | 3 (0.2) | 5 (0.2) | 18 (4.9) | 2 (0.3) |
MVRA, missionary, volunteer, research, aid work, VFR, visiting friends and relatives.
a
Missing or not ascertainable exposure region: Giardia spp. 33 (9%); IBS 117 (20%); Strongyloidiasis 22 (11%); Schistosomiasis 9 (10%); P. falciparum malaria 8 (2%); Dengue 6 (3%); Enteric 4 (4%); Rickettsiosis 1 (1%) and Leishmaniasis 3 (3%).
b
Includes Mexico and countries in the Caribbean, Central and South America.
c
‘Other’ region includes North America, Australia/New Zealand, Western/Eastern Europe and Oceania.